Oncternal Therapeutics, Inc. (ONCT)
Dec 3, 2024 - ONCT trading suspended
0.5266
-0.1670 (-24.12%)
Inactive · Last trade price on Dec 2, 2024
Oncternal Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.49 | 0.8 | 0.57 | 0.3 | 0.18 | 0.11 | 0.2 | 0.17 | 0.38 | 0.19 | 0.75 | 0.56 | 2.13 | 0.88 | 0.75 | 1.59 | 0.59 | 0.62 | 0.58 | 0.74 | |
Revenue Growth (YoY) | 175.98% | 655.66% | 180.30% | 73.68% | -53.14% | -44.50% | -72.79% | -69.24% | -82.05% | -78.37% | -0.27% | -64.99% | 263.76% | 41.73% | 29.41% | 115.76% | 7.54% | -7.57% | 22.98% | 54.30% |
Gross Profit | 0.49 | 0.8 | 0.57 | 0.3 | 0.18 | 0.11 | 0.2 | 0.17 | 0.38 | 0.19 | 0.75 | 0.56 | 2.13 | 0.88 | 0.75 | 1.59 | 0.59 | 0.62 | 0.58 | 0.74 |
Selling, General & Admin | 2.73 | 3.05 | 3.29 | 3.26 | 3.09 | 3.07 | 3.32 | 3.29 | 3.27 | 3.23 | 3.68 | 2.62 | 2.8 | 3.38 | 2.79 | 1.46 | 1.93 | 2.34 | 2.63 | 2.35 |
Research & Development | 6.45 | 6.61 | 6.06 | 6.67 | 7.48 | 6.58 | 9.03 | 8.8 | 8.44 | 8.76 | 6.98 | 6.02 | 8.96 | 5.19 | 3.91 | 2.99 | 3.05 | 3.82 | 2.7 | 2.57 |
Operating Expenses | 9.18 | 9.66 | 9.35 | 9.93 | 10.57 | 9.65 | 12.35 | 12.09 | 11.71 | 11.99 | 10.66 | 8.64 | 11.77 | 8.57 | 6.71 | 4.45 | 4.98 | 6.16 | 5.33 | 4.92 |
Operating Income | -8.68 | -8.86 | -8.78 | -9.64 | -10.39 | -9.55 | -12.14 | -11.92 | -11.33 | -11.8 | -9.91 | -8.08 | -9.64 | -7.69 | -5.96 | -2.86 | -4.4 | -5.54 | -4.75 | -4.18 |
Other Expense (Income) | -0.22 | -0.3 | -0.39 | -0.47 | -0.53 | -0.58 | -0.66 | -0.52 | -0.2 | -0.05 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.3 | - | - | -0.01 | -0.03 |
Pretax Income | -8.46 | -8.56 | -8.39 | -9.16 | -9.86 | -8.97 | -11.49 | -11.4 | -11.13 | -11.74 | -9.9 | -8.07 | -9.63 | -7.68 | -5.95 | -2.56 | -4.4 | -5.54 | -4.74 | -4.16 |
Net Income | -8.46 | -8.56 | -8.39 | -9.16 | -9.86 | -8.97 | -11.49 | -11.4 | -11.13 | -11.74 | -9.9 | -8.07 | -9.63 | -7.68 | -5.95 | -2.56 | -4.4 | -5.54 | -4.74 | -4.16 |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Shares Change | 0.41% | 0.82% | 1.13% | 4.13% | 8.76% | 17.29% | 18.39% | 14.60% | 9.76% | 1.42% | 0.68% | 143.43% | 145.42% | 203.95% | 219.73% | 96.58% | 31.20% | 140.07% | 317.71% | 183.37% |
EPS (Basic) | -2.86 | -2.89 | -2.83 | -3.03 | -3.35 | -3.05 | -3.93 | -4.00 | -4.20 | -4.60 | -4.00 | -3.40 | -3.80 | -3.20 | -2.40 | - | -4.40 | -6.80 | -6.20 | 3.40 |
EPS (Diluted) | -2.86 | -2.89 | -2.83 | -3.03 | -3.35 | -3.05 | -3.93 | -4.00 | -4.20 | -4.60 | -4.00 | -3.40 | -3.80 | -3.20 | -2.40 | - | -4.40 | -6.80 | -6.20 | 3.40 |
Free Cash Flow | -6.95 | -5.82 | -7.44 | -6.42 | -5.51 | -9.26 | -10.97 | -9 | -11.97 | -7.13 | -8.61 | -6.62 | -6.38 | -7.61 | -5.99 | -3.91 | -5.33 | -4.22 | -4.04 | -3.05 |
Free Cash Flow Per Share | -2.35 | -1.97 | -2.51 | -2.18 | -1.87 | -3.15 | -3.75 | -3.18 | -4.42 | -2.85 | -3.48 | -2.68 | -2.58 | -3.08 | -2.44 | -3.85 | -5.29 | -5.20 | -5.26 | -5.90 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -1757.29% | -1106.49% | -1542.88% | -3244.44% | -5804.47% | -9004.72% | -5981.77% | -6967.84% | -2964.66% | -6175.39% | -1328.69% | -1453.24% | -452.87% | -870.89% | -796.66% | -180.16% | -751.28% | -888.44% | -821.97% | -568.07% |
Profit Margin | -1713.36% | -1068.54% | -1474.17% | -3085.52% | -5509.50% | -8458.49% | -5658.62% | -6666.67% | -2912.30% | -6147.12% | -1327.61% | -1451.98% | -452.54% | -869.99% | -795.19% | -161.02% | -751.28% | -888.44% | -819.72% | -564.67% |
Free Cash Flow Margin | -1407.49% | -726.84% | -1307.21% | -2161.28% | -3079.89% | -8738.68% | -5403.45% | -5264.33% | -3132.46% | -3732.98% | -1153.62% | -1189.93% | -299.81% | -861.61% | -800.13% | -246.28% | -910.60% | -677.53% | -698.27% | -413.72% |
EBITDA | -8.43 | -8.52 | -8.36 | -9.14 | -9.79 | -8.93 | -11.45 | -11.37 | -11.09 | -11.68 | -9.86 | -8.03 | -9.59 | -7.64 | -5.91 | -2.52 | -4.36 | -5.5 | -4.7 | -4.06 |
EBITDA Margin | -1706.07% | -1064.17% | -1468.37% | -3077.10% | -5467.60% | -8423.58% | -5640.39% | -6646.20% | -2903.14% | -6113.09% | -1321.72% | -1444.06% | -450.52% | -865.23% | -789.84% | -158.56% | -744.79% | -882.50% | -813.49% | -552.17% |
Depreciation & Amortization | 0.04 | 0.04 | 0.03 | 0.03 | 0.08 | 0.04 | 0.04 | 0.04 | 0.04 | 0.07 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.09 |
EBIT | -8.46 | -8.56 | -8.39 | -9.16 | -9.86 | -8.97 | -11.49 | -11.4 | -11.13 | -11.74 | -9.9 | -8.07 | -9.63 | -7.68 | -5.95 | -2.56 | -4.4 | -5.54 | -4.74 | -4.16 |
EBIT Margin | -1713.36% | -1068.54% | -1474.17% | -3085.52% | -5509.50% | -8458.49% | -5658.62% | -6666.67% | -2912.30% | -6147.12% | -1327.61% | -1451.98% | -452.54% | -869.99% | -795.19% | -161.02% | -751.28% | -888.44% | -819.72% | -564.67% |